Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Diamond

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Advances in Neurology|January 1, 1984
Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's diseaseB I Diamond, G Pasinetti, A Hitri, et al.
Experimental Neurology|March 1, 1977
Differential interactions of phenobarbital and pentobarbital with beta-adrenergic mechanisms in vitro and in vivoH C Sabelli, B I Diamond, J May, et al.
Psychopharmacology Bulletin|January 1, 1987
Atypical and typical neuroleptics and tardive dyskinesiaR L Borison, C Shah, T H White, et al.
Psychopharmacology Bulletin|January 1, 1989
Rebound withdrawal reactions due to clomipramineB I Diamond, R L Borison, R Katz, et al.
Clinical Neuropharmacology|June 1, 1983
Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of actionR L Borison, A Hitri, A J Blowers, et al.
Brain Research|December 7, 1981
Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogenK O Perry, B I Diamond, J Z Fields, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1980
Postsynaptic efficacy of dopamine: possible suppression by estrogenJ H Gordon, R A Gorski, R L Borison, et al.
Research Communications in Chemical Pathology and Pharmacology|August 1, 1978
Metabolism of an amino acid with antidepressant propertiesR L Borison, P J Maple, H S Havdala, et al.
Psychopharmacology Bulletin|January 1, 1992
Risperidone: clinical safety and efficacy in schizophreniaR L Borison, A P Pathiraja, B I Diamond, et al.
Psychopharmacology Bulletin|January 1, 1990
The use of midazolam in acutely agitated psychiatric patientsM Wyant, B I Diamond, E O'Neal, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Advances in Neurology|January 1, 1984
Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's diseaseB I Diamond, G Pasinetti, A Hitri, et al.
Experimental Neurology|March 1, 1977
Differential interactions of phenobarbital and pentobarbital with beta-adrenergic mechanisms in vitro and in vivoH C Sabelli, B I Diamond, J May, et al.
Psychopharmacology Bulletin|January 1, 1987
Atypical and typical neuroleptics and tardive dyskinesiaR L Borison, C Shah, T H White, et al.
Psychopharmacology Bulletin|January 1, 1989
Rebound withdrawal reactions due to clomipramineB I Diamond, R L Borison, R Katz, et al.
Clinical Neuropharmacology|June 1, 1983
Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of actionR L Borison, A Hitri, A J Blowers, et al.
Brain Research|December 7, 1981
Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogenK O Perry, B I Diamond, J Z Fields, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1980
Postsynaptic efficacy of dopamine: possible suppression by estrogenJ H Gordon, R A Gorski, R L Borison, et al.
Research Communications in Chemical Pathology and Pharmacology|August 1, 1978
Metabolism of an amino acid with antidepressant propertiesR L Borison, P J Maple, H S Havdala, et al.
Psychopharmacology Bulletin|January 1, 1992
Risperidone: clinical safety and efficacy in schizophreniaR L Borison, A P Pathiraja, B I Diamond, et al.
Psychopharmacology Bulletin|January 1, 1990
The use of midazolam in acutely agitated psychiatric patientsM Wyant, B I Diamond, E O'Neal, et al.
Pageof 6